Unit of Hematology, AUO Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy.
Hematology and Stem Cell Transplant Unit, Azienda Ospedaliera San Carlo, Potenza, Italy.
Acta Biomed. 2020 May 25;91(S-5):5-12. doi: 10.23750/abm.v91iS-5.9913.
Hodgkin lymphoma (HL) is a rare cancer of the lymphoid system. It clinically presents with swollen lymph nodes and/or systemic symptoms, such as fever, night sweats, or weight loss, as signs of a more advanced stage disease. For the purpose of treatment allocation, HL cases are classified as early-stage favorable, early-stage unfavorable, and advanced-stage disease. Here below we describe four different clinical cases from real life that address some key issues and medical needs that are present in the daily practice with patients affected by advanced stage HL. The four clinical cases are quite heterogeneous, but in each case there are strong inputs to manage a specific category of advanced phase HL patient that is going to be treated with first-line therapy.
霍奇金淋巴瘤(HL)是一种罕见的淋巴系统癌症。它在临床上表现为淋巴结肿大和/或全身症状,如发热、盗汗或体重减轻,这是疾病更晚期的迹象。为了治疗分配的目的,HL 病例被分为早期预后良好、早期预后不良和晚期疾病。下面我们描述了四个来自现实生活中的不同临床病例,这些病例涉及到在治疗晚期 HL 患者的日常实践中存在的一些关键问题和医疗需求。这四个临床病例非常不同,但在每个病例中,都有强烈的信息来管理将要接受一线治疗的特定类别的晚期 HL 患者。